Last reviewed · How we verify

NCT04200534

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Active, enrolled EARLY_PHASE1 Last updated 22 August 2025
What this trial tests

EARLY_PHASE1 trial testing Best Practice in Smoking in 358 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
31 July 2020
Primary endpoint
28 February 2027
28 February 2027

Quick facts

Lead sponsorM.D. Anderson Cancer Center
PhaseEARLY_PHASE1
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment358
Start date31 July 2020
Primary completion28 February 2027
Estimated completion28 February 2027
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

Adults 55 to 77, any sex, with Smoking or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Strategies to improve smoking cessation rates in primary care.
    Lindson N, Pritchard G, Hong B, Fanshawe TR, et al · · 2021 · cited 45× · PMID 34693994 · DOI 10.1002/14651858.cd011556.pub2
  2. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening.
    Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MA, et al · · 2023 · cited 2× · PMID 36878389 · DOI 10.1016/j.cct.2023.107141

Verify or expand the search:

Other trials of Best Practice

Trials testing the same drug.

Other recruiting trials for Smoking

Currently open trials in the same condition.

Other M.D. Anderson Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04200534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing